πŸ•΅οΈ Zymeworks Inc. ($ZYME)

SEC insider & ownership activity, last 12 months Β· CIK 1937653 Β· every row links its SEC filing

Over the last 12 months insiders sold $4.7M with no open-market buying against it. Kenneth Galbraith sold $3.3M (Dec–Jan). No red-flag 8-Ks in the window.

Aug 2025: net +$0 Sep 2025: net +$0 Oct 2025: net +$0 Nov 2025: net +$0 Dec 2025: net -$1.3M Jan 2026: net -$3.4M Mar 2026: net +$0 Mar 2026: net +$0 Apr 2026: net +$0 May 2026: net +$0 Jun 2026: net +$0 Jul 2026: net +$0
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

0 buyers, $0 (0 lots) Β· 4 sellers, $4.7M (10 lots)

InsiderBuysBoughtSellsSoldLast
Kenneth Galbraith0– 4$3.3MJan 12, 2026
Paul Andrew Moore0– 3$721KJan 12, 2026
Jeffrey T L Smith0– 2$476KJan 12, 2026
Mark Hollywood0– 1$139KJan 12, 2026

5%+ holders

HolderStakeClassScheduleEvent
ECOR1 Capital, LLC 30.7% 13DNov 16, 2025 filing β†—
Oleg Nodelman 30.7% 13DNov 16, 2025 filing β†—
ECOR1 Capital Fund Qualified, L.P. 28.8% 13DNov 16, 2025 filing β†—
ECOR1 Capital, LLC 21.3% 13DDec 19, 2024 filing β†—
Oleg Nodelman 21.3% 13DDec 19, 2024 filing β†—
ECOR1 Capital Fund Qualified, L.P. 20.1% 13DDec 19, 2024 filing β†—
Rubric Capital Management LP 9.5% 13GMay 15, 2026 filing β†—
David Rosen 9.5% 13GMay 15, 2026 filing β†—
Perceptive Advisors LLC 5.4% 13GApr 15, 2026 filing β†—
Joseph Edelman 5.4% 13GApr 15, 2026 filing β†—
Perceptive Life Sciences Master Fund, Ltd. 5.4% 13GApr 15, 2026 filing β†—
BVF Partners L P/IL 5.2% 13GNov 14, 2025 filing β†—
BVF INC/IL 5.2% 13GNov 14, 2025 filing β†—
Mark N. Lampert 5.2% 13GNov 14, 2025 filing β†—

Planned insider sales (Form 144)

SellerPlannedApprox. sale date
Jeffrey T L Smith$6.1MMar 6, 2026 filing β†—
Leone D Patterson$715KFeb 17, 2026 filing β†—
Leone D Patterson$3.0MFeb 13, 2026 filing β†—
Leone D Patterson$158KJan 12, 2026 filing β†—
Jeffrey T L Smith$216KJan 12, 2026 filing β†—
Paul Andrew Moore$222KJan 12, 2026 filing β†—
Mark Hollywood$142KJan 12, 2026 filing β†—
Kenneth Galbraith$705KJan 12, 2026 filing β†—
Smith Jeffrey T L$281KJan 5, 2026 filing β†—
Kenneth Galbraith$1.4MJan 5, 2026 filing β†—
Paul Andrew Moore$535KJan 5, 2026 filing β†—
Galbraith, Kenneth$1.3MDec 22, 2025 filing β†—
Derek John Michael Miller$2.8MNov 24, 2025 filing β†—
Neil Gallagher$2.5MNov 21, 2025 filing β†—

Material events (8-K)

ItemEvent date
Material agreement (1.01)Jun 28, 2026 filing β†—
Reg FD disclosure (7.01)Jun 28, 2026 filing β†—
Financial Statements and Exhibits (9.01)Jun 28, 2026 filing β†—
Reg FD disclosure (7.01)May 14, 2026 filing β†—
Other events (8.01)May 14, 2026 filing β†—
Financial Statements and Exhibits (9.01)May 14, 2026 filing β†—
Earnings (2.02)May 7, 2026 filing β†—
Reg FD disclosure (7.01)May 7, 2026 filing β†—
Financial Statements and Exhibits (9.01)May 7, 2026 filing β†—
Officer/director changes (5.02)Mar 31, 2026 filing β†—
Financial Statements and Exhibits (9.01)Mar 31, 2026 filing β†—
Earnings (2.02)Mar 2, 2026 filing β†—
Reg FD disclosure (7.01)Mar 2, 2026 filing β†—
Financial Statements and Exhibits (9.01)Mar 2, 2026 filing β†—
Material agreement (1.01)Mar 2, 2026 filing β†—
New financial obligation (2.03)Mar 2, 2026 filing β†—
Reg FD disclosure (7.01)Mar 2, 2026 filing β†—
Financial Statements and Exhibits (9.01)Mar 2, 2026 filing β†—
Earnings (2.02)Jan 6, 2026 filing β†—
Officer/director changes (5.02)Jan 6, 2026 filing β†—
Other events (8.01)Jan 6, 2026 filing β†—
Financial Statements and Exhibits (9.01)Jan 6, 2026 filing β†—
Shareholder vote (5.07)Dec 30, 2025 filing β†—
Other events (8.01)Nov 17, 2025 filing β†—
Financial Statements and Exhibits (9.01)Nov 17, 2025 filing β†—
Officer/director changes (5.02)Nov 16, 2025 filing β†—
Reg FD disclosure (7.01)Nov 16, 2025 filing β†—
Other events (8.01)Nov 16, 2025 filing β†—
Financial Statements and Exhibits (9.01)Nov 16, 2025 filing β†—
Earnings (2.02)Nov 6, 2025 filing β†—